About Ovoca Bio Plc 
Ovoca Bio Plc
Pharmaceuticals: Major
Ovoca Bio plc (Ovoca) is an Ireland-based biopharmaceutical company. The Company is focused on identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD).
Company Coordinates 
Company Details
Dublin 2, 17 Pembroke Street Upper , DUBLIN None : D02 AT22
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Kirill Golovanov
Interim Chairman of the Board, Chief Executive Officer, Executive Director, Corporate Secretary
Mr. Christopher Wiltshire
Chief Business Officer, Executive Director
Romulo Colindres
Non-Executive Director
Mr. Timothy McCutcheon
Non-Executive Director
Leonid Skoptsov
Non-Executive Director
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals: Major
GBP 1 Million (Micro Cap)
1.00
NA
0.00%
-1.31
15.16%
0.54






